trial · primary record
Multivalent Group B streptococcus vaccine
Healthy
| Phase | Phase 3 |
|---|---|
| Status | RECRUITING |
| Sponsor | Unknown |
| Enrolment | 6000 |
| Primary completion | 2029-03-02 |
| Primary endpoint | The proportion of maternal participants reporting prespecified local reactions within 7 days following study intervention |
| Registry ID | NCT07160244 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-10-28T03:27:35.803Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT07160244
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.